Placebo versus best-available-therapy control group in clinical trials for pharmacologic therapies: Which is better?

Proceedings of the American Thoracic Society

Volumn 4, Issue 7, 2007, Pages 570-573

  Castro, Mario ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Control groups; Placebo; Trials

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; FLUTICASONE PROPIONATE PLUS SALMETEROL; MONTELUKAST; PLACEBO; THEOPHYLLINE;

ASTHMA; CLINICAL RESEARCH; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG RESEARCH; HUMAN; HYPERTENSION; LOW DRUG DOSE; MEDICAL RESEARCH; PACEMAKER; RANDOMIZED CONTROLLED TRIAL; REVIEW; SYNCOPE; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE;

ASTHMA; CONTROLLED CLINICAL TRIALS AS TOPIC; HUMANS; PLACEBOS;

EID: 35148832076     PISSN: 15463222     EISSN: None     Source Type: Journal    
DOI: 10.1513/pats.200706-073JK     Document Type: Review

References (14)

1. Council for International Organizations of Medical Sciences. International ethical guidelines for biomedical research involving human subjects. Geneva, Switzerland: CIOMS; 2002.
2. Horng S, Miller F. Is placebo surgery unethical? N Engl J Med 2002;347:137-139.
3. Conolly S, Sheldon R, Thorpe K, Roberts R, Ellenbogen K, Wilkoff B, Morillo C, Gent M; VPS II Investigators. Pacemaker therapy for prevention of syncope in patients with recurrent severe vasovagal syncope: Second Vasovagal Pacemaker Study (VPS II). JAMA 2003;289:2224-2229.
4. World Medical Association. Declaration of Helsinki: ethical principles for medical research involving human subjects. [internet]. Available at: www.wma.net/e/ethicsunit/helsinki.htm.
5. Neild J, Cameron I. Bronchoconstriction in response to suggestion: its prevention by an inhaled anticholinergic agent. BMJ 1985;290:674.
6. Spector S, Luparello T, Kopetzky M, Souhrada J, Kinsman R. Response of asthmatics to methacholine and suggestion. Am Rev Respir Dis 1976;113:43-50.
7. McFadden EJ, Luparello T, Lyons H, Bleecker E. The mechanism of action of suggestion in the induction of acute asthma attacks. Psychosom Med 1969;31:134-143.
8. American Lung Association Asthma Clinical Research Centers. Clinical trial of low-dose theophylline and montelukast in patients with poorly controlled asthma. Am J Respir Crit Care Med 2007;175:235-242.
9. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987;317:141-145.
10. Michels K, Rothman K. Update on unethical use of placebos in randomised trials. Bioethics 2003;17:925-926.
11. Miller F, Brody H. What makes placebo-controlled trials unethical? Am J Bioeth 2002;2:3-9.
12. Lewis J, Jonsson E, Kreutz G, Sampaio C, van Zwieten-Boot B. Placebo-controlled trials and the Declaration of Helsinki. Lancet 2002;359:1337-1340.
13. American Lung Association Asthma Clinical Research Centers. Randomized comparison of strategies for reducing treatment in mild persistent asthma. N Engl J Med 2007;356:2027-2039.
14. National Asthma Education and Prevention Program. Full report of the expert panel: guidelines for the diagnosis and management of asthma. Expert Panel report 2. Bethesda, MD: National Institutes of Health; 1997. (NIH publ. no. 97-4051)